Appendix 5: Clozapine Monitoring Form 5.1 Clozapine monitoring form 5.2 Guidelines for completion of the clozapine monitoring form Available: Appendix 6: Commencement phase protocol for monitoring patients commenced on clozapine in the community for clozapine-induced myocarditis Patient starting clozapine Baseline: Troponin I or T CRP Echocardiography At least every second On days 7, 14, 21 Ask patients (and advise day for the first 28 and 28: carers if outpatients) to days: report feeling unwell and any CRP symptoms of illness including Blood Pressure Troponin I or T fever, cough, chest pain, shortness of breath, diarrhoea, Pulse (HR) vomiting, nausea, sore throat, Body Temperature myalgia, headache, sweatiness, and urinary Respiration rate discomfort or frequency If the patient develops Signs or symptoms of unidentified illness Troponin greater than twice the upper OR limit of normal
Appendix 5: Clozapine Monitoring Form 5.1 Clozapine monitoring form 5.2 Guidelines for completion of the clozapine monitoring form Available: Appendix 6: Commencement phase protocol for monitoring patients commenced on clozapine in the community for clozapine-induced myocarditis Patient starting clozapine Baseline: Troponin I or T CRP Echocardiography At least every second day for the first 28 days: Blood Pressure Pulse (HR) Body Temperature Respiration rate On days 7, 14, 21 and 28: CRP Troponin I or T Ask patients (and advise carers if outpatients) to report feeling unwell and any symptoms of illness including fever, cough, chest pain, shortness of breath, diarrhoea, vomiting, nausea, sore throat, myalgia, headache, sweatiness, and urinary discomfort or frequency If the patient develops Signs or symptoms of unidentified illness OR Troponin greater than twice the upper limit of normal
Guidelines-for-the-Safe-and-Quality-Use-of-Clozapine-in-the-WA-health-system.docx